Genetic Variants Associated with Neuropeptide Y Autoantibody Levels in Newly Diagnosed Individuals with Type 1 Diabetes

<b>(1)</b> Autoantibodies to the leucine variant of neuropeptide Y (NPY-LA) have been found in individuals with type 1 diabetes (T1D). We investigated the association between the levels of NPY-LA and single nucleotide polymorphisms (SNP) to better understand the genetic regulatory mechan...

Full description

Bibliographic Details
Main Authors: Sara Juul Mansachs, Sofie Olund Villumsen, Jesper Johannesen, Alexander Lind, Simranjeet Kaur, Flemming Pociot
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Genes
Subjects:
Online Access:https://www.mdpi.com/2073-4425/13/5/869
_version_ 1797499596451086336
author Sara Juul Mansachs
Sofie Olund Villumsen
Jesper Johannesen
Alexander Lind
Simranjeet Kaur
Flemming Pociot
author_facet Sara Juul Mansachs
Sofie Olund Villumsen
Jesper Johannesen
Alexander Lind
Simranjeet Kaur
Flemming Pociot
author_sort Sara Juul Mansachs
collection DOAJ
description <b>(1)</b> Autoantibodies to the leucine variant of neuropeptide Y (NPY-LA) have been found in individuals with type 1 diabetes (T1D). We investigated the association between the levels of NPY-LA and single nucleotide polymorphisms (SNP) to better understand the genetic regulatory mechanisms of autoimmunity in T1D and the functional impacts of increased NPY-LA levels. <b>(2)</b> NPY-LA measurements from serum and SNP genotyping were done on 560 newly diagnosed individuals with T1D. SNP imputation with the 1000 Genomes reference panel was followed by an association analysis between the SNPs and measured NPY-LA levels. Additionally, functional enrichment and pathway analyses were done. <b>(3)</b> Three loci (<i>DGKH</i>, <i>DCAF5</i>, and <i>LINC02261</i>) were associated with NPY-LA levels (<i>p</i>-value < 1.5 × 10<sup>−6</sup>), which indicates an association with neurologic and vascular disorders. SNPs associated with variations in expression levels were found in six genes (including <i>DCAF5</i>). The pathway analysis showed that NPY-LA was associated with changes in gene transcription, protein modification, immunological functions, and the MAPK pathway. <b>(4)</b> Conclusively, we found NPY-LA to be significantly associated with three loci (<i>DGKH</i>, <i>DCAF5</i>, and <i>LINC02261</i>), and based on our findings we hypothesize that the presence of NPY-LA is associated with the regulation of the immune system and possibly neurologic and vascular disorders.
first_indexed 2024-03-10T03:49:40Z
format Article
id doaj.art-d16792c344d847c091e07117f43ae5a4
institution Directory Open Access Journal
issn 2073-4425
language English
last_indexed 2024-03-10T03:49:40Z
publishDate 2022-05-01
publisher MDPI AG
record_format Article
series Genes
spelling doaj.art-d16792c344d847c091e07117f43ae5a42023-11-23T11:10:47ZengMDPI AGGenes2073-44252022-05-0113586910.3390/genes13050869Genetic Variants Associated with Neuropeptide Y Autoantibody Levels in Newly Diagnosed Individuals with Type 1 DiabetesSara Juul Mansachs0Sofie Olund Villumsen1Jesper Johannesen2Alexander Lind3Simranjeet Kaur4Flemming Pociot5Department of Children Adolescents, Copenhagen University Hospital Herlev, 2730 Herlev, DenmarkTranslational Type 1 Diabetes Research, Steno Diabetes Center Copenhagen, 2739 Herlev, DenmarkDepartment of Children Adolescents, Copenhagen University Hospital Herlev, 2730 Herlev, DenmarkDepartment of Clinical Sciences, Lund University CRC, Skåne University Hospital, 200 49 Malmo, SwedenTranslational Type 1 Diabetes Research, Steno Diabetes Center Copenhagen, 2739 Herlev, DenmarkDepartment of Children Adolescents, Copenhagen University Hospital Herlev, 2730 Herlev, Denmark<b>(1)</b> Autoantibodies to the leucine variant of neuropeptide Y (NPY-LA) have been found in individuals with type 1 diabetes (T1D). We investigated the association between the levels of NPY-LA and single nucleotide polymorphisms (SNP) to better understand the genetic regulatory mechanisms of autoimmunity in T1D and the functional impacts of increased NPY-LA levels. <b>(2)</b> NPY-LA measurements from serum and SNP genotyping were done on 560 newly diagnosed individuals with T1D. SNP imputation with the 1000 Genomes reference panel was followed by an association analysis between the SNPs and measured NPY-LA levels. Additionally, functional enrichment and pathway analyses were done. <b>(3)</b> Three loci (<i>DGKH</i>, <i>DCAF5</i>, and <i>LINC02261</i>) were associated with NPY-LA levels (<i>p</i>-value < 1.5 × 10<sup>−6</sup>), which indicates an association with neurologic and vascular disorders. SNPs associated with variations in expression levels were found in six genes (including <i>DCAF5</i>). The pathway analysis showed that NPY-LA was associated with changes in gene transcription, protein modification, immunological functions, and the MAPK pathway. <b>(4)</b> Conclusively, we found NPY-LA to be significantly associated with three loci (<i>DGKH</i>, <i>DCAF5</i>, and <i>LINC02261</i>), and based on our findings we hypothesize that the presence of NPY-LA is associated with the regulation of the immune system and possibly neurologic and vascular disorders.https://www.mdpi.com/2073-4425/13/5/869NPY-L autoantibodiesminor autoantigenautoimmunitytype 1 diabetesgenetic regulatory mechanismsGWAS
spellingShingle Sara Juul Mansachs
Sofie Olund Villumsen
Jesper Johannesen
Alexander Lind
Simranjeet Kaur
Flemming Pociot
Genetic Variants Associated with Neuropeptide Y Autoantibody Levels in Newly Diagnosed Individuals with Type 1 Diabetes
Genes
NPY-L autoantibodies
minor autoantigen
autoimmunity
type 1 diabetes
genetic regulatory mechanisms
GWAS
title Genetic Variants Associated with Neuropeptide Y Autoantibody Levels in Newly Diagnosed Individuals with Type 1 Diabetes
title_full Genetic Variants Associated with Neuropeptide Y Autoantibody Levels in Newly Diagnosed Individuals with Type 1 Diabetes
title_fullStr Genetic Variants Associated with Neuropeptide Y Autoantibody Levels in Newly Diagnosed Individuals with Type 1 Diabetes
title_full_unstemmed Genetic Variants Associated with Neuropeptide Y Autoantibody Levels in Newly Diagnosed Individuals with Type 1 Diabetes
title_short Genetic Variants Associated with Neuropeptide Y Autoantibody Levels in Newly Diagnosed Individuals with Type 1 Diabetes
title_sort genetic variants associated with neuropeptide y autoantibody levels in newly diagnosed individuals with type 1 diabetes
topic NPY-L autoantibodies
minor autoantigen
autoimmunity
type 1 diabetes
genetic regulatory mechanisms
GWAS
url https://www.mdpi.com/2073-4425/13/5/869
work_keys_str_mv AT sarajuulmansachs geneticvariantsassociatedwithneuropeptideyautoantibodylevelsinnewlydiagnosedindividualswithtype1diabetes
AT sofieolundvillumsen geneticvariantsassociatedwithneuropeptideyautoantibodylevelsinnewlydiagnosedindividualswithtype1diabetes
AT jesperjohannesen geneticvariantsassociatedwithneuropeptideyautoantibodylevelsinnewlydiagnosedindividualswithtype1diabetes
AT alexanderlind geneticvariantsassociatedwithneuropeptideyautoantibodylevelsinnewlydiagnosedindividualswithtype1diabetes
AT simranjeetkaur geneticvariantsassociatedwithneuropeptideyautoantibodylevelsinnewlydiagnosedindividualswithtype1diabetes
AT flemmingpociot geneticvariantsassociatedwithneuropeptideyautoantibodylevelsinnewlydiagnosedindividualswithtype1diabetes